Skip to main navigation Skip to search Skip to main content

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

  • AOCS study group
  • , EMBRACE Study
  • , OPAL Study Group
  • , KConFab Investigators
  • , GEMO Study Collaborators
  • , HEBON Study
  • Netherlands Cancer Institute
  • Moffitt Cancer Center
  • Wellcome Trust Sanger Institute
  • University of Cambridge
  • Cedars-Sinai Medical Center
  • Mayo Clinic Rochester, MN
  • Duke University
  • Queensland Institute of Medical Research
  • Université Laval
  • Amsterdam University Medical Center
  • Radboud University Nijmegen
  • Netherlands Comprehensive Cancer Organisation
  • Johns Hopkins University
  • Leeds Teaching Hospitals NHS Trust
  • University of Toronto
  • University of California at Irvine
  • N.N. Alexandrov National Cancer Centre of Belarus
  • ‘Agii Anargiri’ Cancer Hospital
  • Universitätsklinikum Kiel
  • University of Texas MD Anderson Cancer Center
  • Karolinska Institutet
  • IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
  • University Hospital
  • Royal Marsden NHS Foundation Trust
  • Centre Léon Bérard
  • Landspitali University Hospital
  • University of Iceland
  • Oregon Health and Science University
  • Friedrich-Alexander University Erlangen-Nürnberg
  • Vanderbilt University
  • Spanish National Cancer Research Centre (CNIO)
  • AvMonforte de Lemos
  • Russian Academy of Sciences
  • University Health Network
  • Massachusetts General Hospital
  • University of Bergen
  • National Institutes of Health
  • City of Hope National Med Center
  • Maastricht University

Research output: Contribution to journalArticlepeer-review

389 Scopus citations

Abstract

To identify common alleles associated with different histotypes of epithelial ovarian cancer (EOC), we pooled data from multiple genome-wide genotyping projects totaling 25,509 EOC cases and 40,941 controls. We identified nine new susceptibility loci for different EOC histotypes: six for serous EOC histotypes (3q28, 4q32.3, 8q21.11, 10q24.33, 18q11.2 and 22q12.1), two for mucinous EOC (3q22.3 and 9q31.1) and one for endometrioid EOC (5q12.3). We then performed meta-analysis on the results for high-grade serous ovarian cancer with the results from analysis of 31,448 BRCA1 and BRCA2 mutation carriers, including 3,887 mutation carriers with EOC. This identified three additional susceptibility loci at 2q13, 8q24.1 and 12q24.31. Integrated analyses of genes and regulatory biofeatures at each locus predicted candidate susceptibility genes, including OBFC1, a new candidate susceptibility gene for low-grade and borderline serous EOC.

Original languageEnglish
Pages (from-to)680-691
Number of pages12
JournalNature Genetics
Volume49
Issue number5
DOIs
StatePublished - May 1 2017

Fingerprint

Dive into the research topics of 'Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer'. Together they form a unique fingerprint.

Cite this